Linked Life Data

20696677

Source:http://linkedlifedata.com/resource/pubmed/id/20696677

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20696677rdf:typepubmed:Citationlld:pubmed
pubmed-article:20696677lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C1512288lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0278802lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0008838lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0079083lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0144576lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:20696677lifeskim:mentionsumls-concept:C0205179lld:lifeskim
pubmed-article:20696677pubmed:issue3lld:pubmed
pubmed-article:20696677pubmed:dateCreated2011-2-23lld:pubmed
pubmed-article:20696677pubmed:abstractTextThe purpose of this study is to assess the efficacy and safety of treatment with taxane plus platinum in combination therapies for advanced or recurrent endometrial carcinoma.lld:pubmed
pubmed-article:20696677pubmed:languageenglld:pubmed
pubmed-article:20696677pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:citationSubsetIMlld:pubmed
pubmed-article:20696677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20696677pubmed:statusMEDLINElld:pubmed
pubmed-article:20696677pubmed:monthMarlld:pubmed
pubmed-article:20696677pubmed:issn1569-8041lld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:WatanabeYYlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:NomuraHHlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:TakahashiFFlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:KonishiIIlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:HiuraMMlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:JoboTTlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:HataeMMlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:KatsumataNNlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:YaegashiNNlld:pubmed
pubmed-article:20696677pubmed:authorpubmed-author:AokiDDlld:pubmed
pubmed-article:20696677pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20696677pubmed:volume22lld:pubmed
pubmed-article:20696677pubmed:ownerNLMlld:pubmed
pubmed-article:20696677pubmed:authorsCompleteYlld:pubmed
pubmed-article:20696677pubmed:pagination636-42lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:meshHeadingpubmed-meshheading:20696677...lld:pubmed
pubmed-article:20696677pubmed:year2011lld:pubmed
pubmed-article:20696677pubmed:articleTitleRandomized phase II study comparing docetaxel plus cisplatin, docetaxel plus carboplatin, and paclitaxel plus carboplatin in patients with advanced or recurrent endometrial carcinoma: a Japanese Gynecologic Oncology Group study (JGOG2041).lld:pubmed
pubmed-article:20696677pubmed:affiliationDepartment of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo, Japan.lld:pubmed
pubmed-article:20696677pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20696677pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:20696677pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:20696677pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:20696677pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed